Arab Journal of Gastroenterology
Volume 11, Issue 1 , Pages 35-38 , March 2010

The model of end-stage liver disease (MELD) score in predicting postoperative liver failure after hepatic resection of hepatocellular carcinoma in cirrhotic patients: The Tunisian experience

  • Saber Mannai

      Affiliations

    • Department of Surgery and Liver Transplantation, Mongi Slim Hospital, La Marsa, Tunisia
    • Corresponding Author InformationCorresponding author. Address: Hôpital Mongi Slim MARSA, Surgery Department, Sidi Daoud, La Marsa, 2070, Tunisia.
    • ,
  • Nabil Frikha

      Affiliations

    • Department of Anesthesia and Intensive Care Medicine, Mongi Slim Hospital, La Marsa, Tunisia
    • ,
  • Houcine Maghrebi

      Affiliations

    • Department of Surgery and Liver Transplantation, Mongi Slim Hospital, La Marsa, Tunisia
    • ,
  • Nafaa Arfa

      Affiliations

    • Department of Surgery and Liver Transplantation, Mongi Slim Hospital, La Marsa, Tunisia
    • ,
  • Hafedh Mestiri

      Affiliations

    • Department of Surgery and Liver Transplantation, Mongi Slim Hospital, La Marsa, Tunisia
    • ,
  • Mohamed Tahar Khalfallah

      Affiliations

    • Department of Surgery and Liver Transplantation, Mongi Slim Hospital, La Marsa, Tunisia
    • ,
  • Mohamed Salah Ben Ammar

      Affiliations

    • Department of Anesthesia and Intensive Care Medicine, Mongi Slim Hospital, La Marsa, Tunisia

Received 23 August 2009 ,Accepted 23 December 2009.

References 

  1. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470
  2. Freeman RB, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8(9):851–858
  3. Pugh RN, Murray Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649
  4. Couinaud C. Bases anatomiques des hépatectomies gauche et droite reglées: techniques qui en découlent [Anatomic principles of left and right regulated hepatectomy: technics.]. J Chir (Paris). 1954;70(12):933–966
  5. Okamoto E, Kyo A, Yamanaka N, et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery. 1984;95(5):586–592
  6. Yamanaka N, Okamoto E, Kuwata K, et al. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg. 1984;200(5):658–663
  7. Yamanaka N, Okamoto E, Oriyama T, et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg. 1994;219(4):342–346
  8. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85
  9. Child CGTJ. Surgery and portal hypertension. In:  Child CG editors. The liver and portal hypertension. Philadelphia: WB Saunders; 1964;p. 50–72
  10. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871
  11. Nagao T, Inoue S, Goto S, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg. 1987;205(1):33–40
  12. Nagasue N, Yukaya H, Ogawa Y, et al. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery. 1986;99(6):694–701
  13. Hemming AW, Scudamore CH, Shackleton CR, et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163(5):515–518
  14. Ozawa K. Hepatic function and liver resection. J Gastroenterol Hepatol. 1990;5(3):296–309
  15. Merkel C, Gatta A, Zoli M, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci. 1991;36(9):1197–1203
  16. Gill RA, Goodman MW, Golfus GR, et al. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg. 1983;198(6):701–704
  17. Redaelli CA, Dufour JF, Wagner M, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg. 2002;235(1):77–85
  18. Huo T, Lee S, Lin H. Selecting an optimal prognostic scoring system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008;606–613
  19. Farnsworth N, Fagan SP, Berger DH, et al. Child–Turcotte–Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004;188(5):580–583
  20. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo end-stage liver disease. Hepatology. 2001;33(2):473–475
  21. Esnaola NF, Mirza N, Lauwers GY, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France and Japan. Ann Surg. 2003;238(5):711–719
  22. Heuman DM, Abou Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40(4):802–810
  23. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41(1):32–39
  24. Befeler AS, Palmer DE, Hoffman M, et al. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child–Turcotte–Pugh classification in predicting outcome. Arch Surg. 2005;140(7):650;4; discussion 655
  25. Northup PG, Wanamaker RC, Lee VD, et al. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242(2):244–251
  26. Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12(6):966–971
  27. Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an american cohort. Hepatology. 2005;41(4):707–716
  28. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234(1):63–70
  29. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg. 2002;235(5):722;30; discussion 730–731
  30. Lauwers GY, Terris B, Balis UJ, et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol. 2002;26(1):25–34

PII: S1687-1979(09)00342-6

doi: 10.1016/j.ajg.2009.12.015

Arab Journal of Gastroenterology
Volume 11, Issue 1 , Pages 35-38 , March 2010

Article Tools

* Image Usage & Resolution